[Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
Institutionen för klinisk neurovetenskap, avdelningen för psykiatri och neurokemi, Mölndals sjukhus.
A
A
Wallin
D000544:Alzheimer Disease / Q000188:drug therapy / Q000517:prevention & control*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003657:Decision Making; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010277:Parasympathomimetics / Q000009:adverse effects / Q000627:therapeutic use*; D013619:Tacrine / Q000009:adverse effects / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D010277:Parasympathomimetics; D013619:Tacrine
Takrin mot Alzheimer? Annu osäkert vilka patienter som kan dra nytta av behandlingen.